Trials / Conditions / Cancer of Unknown Primary
Cancer of Unknown Primary
8 registered clinical trials studyying Cancer of Unknown Primary — 5 currently recruiting.
| Status | Trial | Sponsor | Phase |
|---|---|---|---|
| Not Yet Recruiting | Phase II Trial of Lu-177 FAP-2286 in Patients With Carcinoma of Unknown Primary NCT07434180 | Peter MacCallum Cancer Centre, Australia | Phase 2 |
| Not Yet Recruiting | Pucotenlimab Combined with MRG002 for HER2-positive Cancer of Unknown Primary NCT06869174 | Zhiguo Luo, MD, PhD | Phase 2 |
| Recruiting | Enabling Genomic Testing in Cancer of Unknown Primary NCT06695494 | The Christie NHS Foundation Trust | — |
| Recruiting | [18F]F-FAPI PET-CT to Identify Carcinoma of Unknown Primary Origin NCT06644716 | Erasmus Medical Center | N/A |
| Recruiting | Agnostic Therapy in Rare Solid Tumors NCT06638931 | Instituto do Cancer do Estado de São Paulo | Phase 2 |
| Unknown | Tislelizumab Combined With Chemotherapy in the Treatment of Bone Metastases of Unknown Primary NCT05241132 | Wei Xu | Phase 2 |
| Unknown | PD-1 Inhibitor and Nab-paclitaxel and Bevacizumab in CUP NCT04848597 | Fudan University | Phase 2 |
| Completed | Palbociclib With Cisplatin or Carboplatin in Advanced Solid Tumors NCT02897375 | Emory University | Phase 1 |